Oxidation of intracellular and extracellular fatty acids in skeletal muscle

European Journal of Lipid Science and Technology

Volumn 110, Issue 1, 2008, Pages 5-15

  Guo, ZengKui ^a   Jensen, Michael D ^a   Xu, Jinze ^a   Zhou, Lianzhen ^a   Persson, Xuan Mai T ^a   Balagopal, Prabhakaran ^b   Yarasheski, Kevin ^c  

^a MAYO CLINIC   (United States)

^b Nemour Children's Clinic   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acid; Intracellular; LC MS; Oxidation; Rats; Skeletal muscle; Stable isotope

Indexed keywords

RATTUS;

EID: 38749086124     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200600267     Document Type: Article

References (58)

1. S. K. Raatz, D. Bibus, W. Thomas, P. Kris-Etherton: Total fat intake modifies plasma fatty acid composition in humans. J Nutr. 2001, 131, 231-234.
2. M. L. Elks: Fat oxidation and diabetes of obesity: The Randle hypothesis revisited. Med Hypotheses. 1990, 33, 257-260.
3. A. N. Carley, D. L. Severson: Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta. 2005, 1734, 112-126.
4. P. Ferre: The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004, 53 Suppl 1, S43-S50.
5. J. Buchanan, P. K. Mazumder, P. Hu, G. Chakrabarti, M. W. Roberts, U. J. Yun, R. C. Cooksey, S. E. Litwin, E. D. Abel: Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 2005, 146, 5341-5349.
6. J. P. Felber, E. Ferrannini, A. Golay, H. U. Meyer, D. Theibaud, B. Curchod, E. Maeder, E. Jequier, R. A. DeFronzo: Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes. 1987, 36, 1341-1350.
7. E. W. Kraegen, G. J. Cooney, J. M. Ye, A. L. Thompson, S. M. Furler: The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes. 2001, 109 Suppl 2, S189-S201.
8. P. J. Randle, P. B. Garland, C. N. Hales: The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963, 1, 785-789.
9. B. N. Finck, C. Bernal-Mizrachi, D. H. Han, T. Coleman, N. Sambandam, L. L. LaRiviere, J. O. Holloszy, C. F. Semenkovich, D. P. Kelly: A potential link between muscle peroxisome proliferator-activated receptor-alpha signaling and obesity-related diabetes. Cell Metab. 2005, 1, 133-144.
10. G. Boden, G. I. Shulman: Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002, 32 Suppl 3, 14-23.
11. A. Zorzano, T. W. Balon, L. J. Brady, P. Rivera, L. P. Garetto, J. C. Young, M. N. Goodman, N. B. Ruderman: Effects of starvation and exercise on concentrations of citrate, hexose phosphates and glycogen in skeletal muscle and heart. Evidence for selective operation of the glucose-fatty acid cycle. Biochem J. 1985, 232, 585-591.
12. B. C. Bergman, G. E. Butterfield, E. E. Wolfel, G. A. Casazza, G. D. Lopaschuk, G. A. Brooks: Evaluation of exercise and training on muscle lipid metabolism. Am J Physiol. 1999, 276, E106-E117.
13. A. E. Jeukendrup: Regulation of fat metabolism in skeletal muscle. Ann N Y Acad Sci. 2002, 967, 217-235.
14. R. J. Maughan, C. Williams: Muscle citrate content and the regulation of metabolism in fed and fasted human skeletal muscle. Clin Physiol. 1982, 2, 21-27.
15. G. Perdomo, S. R. Commerford, A. M. Richard, S. H. Adams, B. E. Corkey, R. M. O'Doherty, N. F. Brown: Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem. 2004, 279, 27177-27186.
16. P. J. Randle: Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabeles Metab Rev. 1998, 14, 263-283.
17. G. I. Shulman: Cellular mechanisms of insulin resistance. J Clin Invest. 2000, 106, 171-176.
18. G. J. Cooney, A. L. Thompson, S. M. Furier, J. Ye, H. W. Kraegen: Muscle long-chain acyl CoA esters and insulin resistance. Ann N Y Acad Sci. 2002, 967, 196-207.
19. J. Fruebis, T. S. Tsao, S. Javorschi, D. Ebbets-Reed, M. R. Erickson, F. T. Yen, B. E. Bihain, H. F. Lodish: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001, 98, 2005-2010.
20. A. C. Smith, C. R. Bruce, D. J. Dyck: AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle. J Physiol. 2005, 565, 537-546.
21. L. P. Turcotte, J. R. Swenberger, A. J. Yee: High carbohydrate availability increases LCFA uptake and decreases LCFA oxidation in perfused muscle. Am J Physiol Endocrinol Metab. 2002, 282, E177-E183.
22. P. D. Gollnick, B. Saltin: Significance of skeletal muscle oxidative enzyme enhancement with endurance training. Clin Physiol. 1982, 2, 1-12.
23. W. C. Stanley, S. R. Meadows, K. M. Kivilo, B. A. Roth, G. D. Lopaschuk: beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content. Am J Physiol Heart Circ Physiol. 2003, 285, H1626-H1631.
24. B. B. Rasmussen, U. C. Holmback, E. Volpi, B. Morio-Liondore, D. Paddon-Jones, R. R. Wolfe: Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest. 2002, 110, 1687-1693.
25. C. K. Stone, R. A. Pooley, T. R. DeGrado, B. Renstrom, R. J. Nickles, S. H. Nellis, A. J. Liedtke, J. E. Holden: Myocardial uptake of the fatty acid analog 14-fluorine-18-fluoro-6-thio-heptadecanoic acid in comparison to beta-oxidation rates by tritiatedpalmitate. J Nucl Med. 1998, 39, 1690-1696.
26. N. D. Oakes, A. Kjellstedt, G. B. Forsberg, T. Clementz, G. Camejo, S. M. Furier, E. W. Kraegen, M. Olwegard-Halvarsson, A. B. Jenkins, B. Ljung: Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer. J Lipid Res. 1999, 40, 1155-1169.
27. C. E. Torgan, J. T. Brozinick, Jr., G. M. Kastello, J. L. Ivy: Muscle morphological and biochemical adaptations to training in obese Zucker rats. J Appl Physiol. 1989, 67, 1807-1813.
28. D. E. Kelley, B. Goodpaster, R. R. Wing, J. A. Simoneau: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol. 1999, 277, E1130-E1141.
29. D. A. Pan, S. Lillioja, A. D. Kriketos, M. R. Milner, L. A. Baur, C. Bogardus, A. B. Jenkins, L. H. Storlien: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 1997, 46, 983-988.
30. 1H NMR spectroscopy study [published errata appear in Diabetologia 1999, 42, 386 and 1999, 42, 1269]. Diabetologia. 1999, 42, 113-116.
31. ZK, Guo, M. Jensen: Accelerated intramyocellular triglyceride synthesis in skeletal muscle of high-fat-induced obese rats. Intl J Obesity. 2003, 27, 1014-1019.
32. N. D. Oakes, G. J. Cooney, S. Camilleri, D. J. Chisholm, E. W. Kraegen: Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes. 1997, 46, 1768-1774.
33. Y. T. Zhou, P. Grayburn, A. Karim, M. Shimabukuro, M. Higa, D. Baetens, L. Orci, R. H. Unger: Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci USA. 2000, 97, 1784-1789.
34. K. Koyama, G. Chen, Y. Lee, R. H. Unger: Tissue triglycerides, insulin resistance, and insulin production: Implications for hyperinsulinemia of obesity. Am J Physiol. 1997, 273, E708-E713.
35. F. Diraison, V. Large, H. Brunengraber, M. Beylot: Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty-acid oxidation in NIDDM. Diabetologia. 1998, 41, 212-220.
36. J. D. McGarry: Travels with carnitine palmitoyltransferase. I: From liver to germ cell with stops in between. Biochem Soc Trans. 2001, 29, 241-245.
37. B. Akesson: Turnover of palmitoylcarnitine in rat liver. Biochim Biophys Acta. 1975, 398, 485-489.
38. ZK. Guo, L. Zhou: Muscle type-dependent responses to insulin in intramyocellular triglyceride turnover in obese rats. Obes Res. 2005, 13, 2081-2087.
39. ZK. Guo, L. Zhou: Dual tail catheters for infusion and sampling in rats as an efficient platform for metabolic experiments. Lab Anim (NY). 2003, 32, 45-48.
40. ZK. Guo, L. Zhou, M. D. Jensen: Acute hyperinsulinemia inhibits intramyocellular triglyceride synthesis in high fat-fed obese rats. J Lipid Res. 2006, 47, 2640-2646.
41. ZK. Guo, K. Yarasheski, M. D. Jensen: High-precision isotopic analysis of palmitoylcarnitine by liquid chromatography/ electrospray ionization ion-trap tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20, 3361-3366.
42. ZK. Guo, L. Zhou: Evidence for increased and insulin-resistant lipolysis in skeletal muscle of high-fat-fed rats. Metabolism. 2004, 53, 794-798.
43. L. C. Groop, R. C. Bonadonna, M. Shank, A. S. Petrides, R. A. DeFronzo: Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest. 1991, 87, 83-89.
44. ZK. Guo, B. Burguera, M. D. Jensen: Kinetics of intramuscular triglyceride fatty acids in exercising humans. J Appl Physiol 2000, 89, 2057-2064.
45. 14C oxidation and incorporation into neutral lipids by skeletal muscle in vitro. J Lipid Res. 1961, 2, 376-382.
46. D. M. Muoio, G. L. Dohm, E. B. Tapscott, R. A. Coleman: Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol. 1999, 276, E913-E921.
47. L. P. Turcotte, J. R. Swenberger, M. Z. Tucker, A. J. Yee: Training-induced elevation in FABP(PM) is associated with increased palmitate use in contracting muscle. J Appl Physiol. 1999, 87, 285-293.
48. J. Y. Kim, R. C. Hickner, R. L. Cortright, G. L. Dohm, J. A. Houmard: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab. 2000, 279, E1039-E1044.
49. N. Alam, E. D. Saggerson: Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle. Biochem J. 1998, 334 (Pt 1), 233-241.
50. M. Laville, V. Rigalleau, J. P. Riou, M. Beylot: Respective role of plasma nonesterified fatty acid oxidation and total lipid oxidation in lipid-induced insulin resistance. Metabolism. 1995, 44, 639-644.
51. J. D. Pullar, A. J. Webster: The energy cost of fat and protein deposition in the rat. Br J Nutr. 1977, 37, 355-363.
52. R. B. Armstrong, R. O. Phelps: Muscle fiber type composition of the rat hindlimb. Am J Anal. 1984, 171, 259-272.
53. N. Baker, D. B. Learn, K. R. Bruckdorfer: Re-evaluation of lipogenesis from dietary glucose carbon in liver and carcass of mice. J Lipid Res. 1978, 19, 879-893.
54. J. H. Veerkamp, H. T. van Moerkerk: Peroxisomal fatty acid oxidation in rat and human tissues. Effect of nutritional state, clofibrate treatment and postnatal development in the rat. Biochim Biophys Acta. 1986, 875, 301-310.
55. L. J. Debeer, G. P. Mannaerts: The mitochondrial and peroxisomal pathways of fatty acid oxidation in rat liver. Diabetes Metab. 1983, 9, 134-140.
56. ZK. Guo, L. Zhou: Substrate concentration and metabolism in left and right muscles of rats. Metabolism. 2003, 52, 1571-1575.
57. M. E. Rubio-Gozalbo, J. A. Bakker, H. R. Waterham, R. J. Wanders: Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med. 2004, 25, 521-532.
58. M. A. Stavinoha, J. W. RaySpellicy, M. F. Essop, C. Graveleau, E. D. Abel, M. L. Hart-Sailors, H. J. Mersmann, M. S. Bray, M. E. Young: Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab. 2004, 287, E888-E895.